Atlas Trials

Avexa

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Avexa

RecordFirmDate
A Long Term Safety Study of Apricitabine in HIV-infected Patients (NCT00686270)Avexa2008-05-01
Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection (NCT00612898)Avexa2008-02-01
A Long Term, Safety Study of Apricitabine in HIV-infected Subjects (NCT00367952)Avexa2006-08-01
Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together (NCT00352066)Avexa2006-07-01
A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects (NCT00334659)Avexa2006-06-01
AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV (NCT00126880)Avexa2005-07-01

Track Avexa automatically

Every clearance here is in the API, with alerts when new ones post.